Moleculin Biotech
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -8 | -9 | -21 | -29 |
EBITDA | -12,837 | 15,561 | -25,377 | -7,611 |
EBIT | -12,845 | 15,552 | -25,399 | -7,640 |
Net Income | -12,845 | 15,552 | -25,399 | -7,640 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,111 | -5,366 | -7,223 | -5,582 |
Cash | 10,317 | 8,878 | 6,703 | 7,557 |
Basic Shares | 4,124 | 3,199 | 1,492 | 621 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -90 | -126 | -127 | -222 |
EBITDA | -33,470 | -21,637 | -29,642 | -28,895 |
EBIT | -33,560 | -21,763 | -29,769 | -29,025 |
Net Income | -33,560 | -21,763 | -29,769 | -29,025 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -22,735 | -23,875 | -24,225 | -27,706 |
Cash | 8,878 | 4,278 | 23,550 | 43,145 |
Basic Shares | 1,184 | 137 | 79 | 76 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$3.54 |
2025-12-31 | $4.82 |
2025-09-30 | -$0.68 |
2025-06-30 | -$0.49 |